Serum Institute lands another vaccine collaboration, pushing business beyond the pandemic
The Serum Institute has been busy keeping up with the demand for Covid-19 vaccines. And although demand has eased, the team hasn’t taken its foot off the new business gas pedal. On Tuesday, it landed another collaboration with a biotech to expand its work beyond the pandemic.
UK-based biotech Wockhardt inked a new deal with Serum Life Sciences UK, a subsidiary of the Serum Institute of India, to help deliver a global vaccine program. The move will create a new sterile fill-finish facility in North Wales, while a profit-sharing agreement will deliver another 150 million doses of several different vaccines.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.